Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-026108
Filing Date
2017-02-01
Accepted
2017-01-31 19:02:03
Documents
3
Effectiveness Date
2017-02-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A d306779ddefa14a.htm DEFA14A 24056
2 GRAPHIC g306779g54x34.jpg GRAPHIC 265482
3 GRAPHIC g306779g86p32.jpg GRAPHIC 223616
  Complete submission text file 0001193125-17-026108.txt   699297
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 000-21898 | Film No.: 17562617
SIC: 2834 Pharmaceutical Preparations